drugset / Trial / NCT07472361
A Study of ENX-104 in Healthy Participants
RandomizedCrossoverOpen-labelOther
Summary
The study is designed to evaluate the relative bioavailability, safety, and tolerability of a single dose of ENX-104 administered orally as a solution fasted, a tablet fasted, or a tablet with a high fat meal in healthy participants
Timeline
- Start
- 2026-02-25
- Primary completion
- 2026-03-19
- Completion
- 2026-03-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ENX-104 | Unknown | — | Oral |
Indications
No indication recorded.